Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-12-07 2019-12-06
Drug Identification Number 02230248 02230248
Brand name LUPRON DEPOT LUPRON DEPOT
Common or Proper name Lupron depot 22.5mg Lupron depot 22.5mg
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients LEUPROLIDE ACETATE LEUPROLIDE ACETATE
Strength(s) 22.5MG 22.5MG
Dosage form(s) POWDER FOR SUSPENSION, SUSTAINED-RELEASE POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 syringe (22.5mg) 1 syringe (22.5mg)
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-11-21 2019-11-21
Actual start date 2019-11-21 2019-11-21
Estimated end date 2019-12-06 2019-12-06
Actual end date 2019-12-06 2019-12-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments We are pleased to share that this dossier has been resolved as per expected due date and orders are now being processed as per our normal process. Thank you for your continued partnership We are pleased to share that this dossier has been resolved as per expected due date and orders are now being processed as per our normal process. Thank you for your continued partnership
Health Canada comments